398 related articles for article (PubMed ID: 35168674)
1. Major coagulation disorders and parameters in COVID-19 patients.
Teimury A; Khameneh MT; Khaledi EM
Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
[TBL] [Abstract][Full Text] [Related]
2. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
3. Focus on coronavirus disease 2019 associated coagulopathy.
Yang XH; Li RR; Sun RH; Liu J; Chen DC
Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
[No Abstract] [Full Text] [Related]
4. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
5. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
6. [COVID-19: Coagulopathy and thrombosis].
Tazi Mezalek Z
Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
[TBL] [Abstract][Full Text] [Related]
7. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
8. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
Hong LZ; Shou ZX; Zheng DM; Jin X
Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic Complications of COVID-19 Infection: A Review.
Castro RA; Frishman WH
Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
11. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
[TBL] [Abstract][Full Text] [Related]
12. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Levi M; Iba T
Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
[TBL] [Abstract][Full Text] [Related]
14. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
15. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM
Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013
[TBL] [Abstract][Full Text] [Related]
16. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19.
Elieh Ali Komi D; Rahimi Y; Asghari R; Jafari R; Rasouli J; Mohebalizadeh M; Abbasi A; Nejadrahim R; Rezazadeh F; Shafiei-Irannejad V
Front Immunol; 2021; 12():762782. PubMed ID: 34975853
[TBL] [Abstract][Full Text] [Related]
18. Coagulopathy in COVID-19.
Iba T; Levy JH; Levi M; Thachil J
J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
[TBL] [Abstract][Full Text] [Related]
19. Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.
Sayyadi M; Khosravi M; Ghaznavi-Rad E
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):518-522. PubMed ID: 33506943
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 coagulopathy vs disseminated intravascular coagulation.
Levi M
Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
